We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » VaxGen Cutting Half Its Work Force After Contract Cancellation
VaxGen Cutting Half Its Work Force After Contract Cancellation
January 12, 2007
VaxGen announced that it will cut 51 percent of its work force as part of restructuring efforts, following the federal government’s
unilateral cancellation of what would have been an $877.5 million contract to develop a next-generation anthrax vaccine.